Returns % | |
1 Month Return | -5.22 % |
3 Month Return | -14.25 % |
1 Year Return | -32.52 % |
Source: S&P Global Market Intelligence
Alembic Pharmaceuticals Ltd price forecast by 17 analysts
Upside of26.71%
High
₹944
Target
₹630.24
Low
₹550
Current Price: ₹489.65
Target Price: ₹630.24
Source: S&P Global Market Intelligence
Alembic Pharma share price declined. However, US regulator inspections gave a clean chit in its Karakhadi facility.
Alembic Pharma fell 1% on 09 Mar, 2023
Alembic Pharma declined 1% amid weakness in Pharma stocks. The pharma company's Brexpiprazole tablets received US regulator approval recently which capped the losses.
Alembic Pharmaceuticals fell 3% on 08 Mar, 2023
Alembic Pharma share price fell amid weakness in Pharma stocks. Reports of the company getting US regulator's approval for hypertension treatment drug capped the losses.
Alembic Pharma jumped 5% on 06 Mar, 2023
Alembic Pharma share price gained after the pharma major's injection for breast cancer received approval from the US regulator.
Alembic Pharma gained marginally on 03 Mar, 2023
Alembic Pharma share price moved marginally higher. The company's board approved an impairment charge of Rs 1,150 crores for three Gujarat plants which capped gains.
Alembic Pharma dipped 1% on 01 Mar, 2023
Alembic Pharma share price ended lower following the weakness in most Pharma stocks. Reports of Alembic Pharma receiving a final USFDA approval for cancer treatment injections capped the losses.
Alembic Pharma dropped 1% on 13 Feb, 2023
Alembic Pharma share price declined to touch 52-week lows. Overall weakness in the pharma sector continued to hurt the stock.
Alembic Pharmaceuticals Ltd in the last 5 years
Lowest (11.53x)
March 23, 2020
Today (43.52x)
March 22, 2023
Highest (50.18x)
January 3, 2023
43.52x
Price to Earnings TTM Ratio
Mutual Funds have increased holdings from 5.36% to 5.87% in Dec 2022 quarter
Revenue is up for the last 3 quarters, 1.26KCr → 1.50KCr (in ₹), with an average increase of 8.3% per quarter
Retail Investor have increased holdings from 12.53% to 12.65% in Dec 2022 quarter
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 199.6% return, outperforming this stock by 187.9%
In the last 1 year, Dr Reddys Laboratories Ltd has given 8.4% return, outperforming this stock by 40.9%
Promoters holdings remained unchanged at 69.61% of holdings in Dec 2022 quarter
In the last 1 year, APLLTD stock has moved down by -32.5%
Foreign Institutions have decreased holdings from 5.32% to 4.99% in Dec 2022 quarter
Netprofit is down for the last 2 quarters, 133.35Cr → 121.92Cr (in ₹), with an average decrease of 8.6% per quarter
Investors | Holdings % | Prev. 4 periods | 3M change |
---|---|---|---|
Promoter Holdings | 69.61% | 0.00 | |
Foreign Institutions | 4.99% | ||
Mutual Funds | 5.87% | 9.53 | |
Retail Investors | 12.65% | 0.96 | |
Others | 6.89% |
Alembic Pharmaceuticals Ltd’s net profit fell -29.03% since last year same period to ₹121.92Cr in the Q3 2022-2023. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -8.57% fall in its net profits since last 3-months.
Read MoreIn the quarter ending June 2022, Alembic Pharmaceuticals Ltd has declared dividend of ₹10 - translating a dividend yield of 4.83%.
Read MoreOrganisation | Alembic Pharmaceuticals Ltd |
Headquarters | Vadodara |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Alembic Pharmaceuticals Ltd(APLLTD) share price today is ₹489.65 (last updated 23 Mar, 2023 at 04:01 PM)
Alembic Pharmaceuticals Ltd(APLLTD) | Price |
---|---|
52 Week High | ₹792.90 |
52 Week Low | ₹476.05 |
Alembic Pharmaceuticals Ltd(APLLTD) | Returns (%) |
---|---|
1 Day Returns | -1.56% |
1 Month Returns | -5.22% |
1 Year Returns | -32.52% |
3 Year Returns | 11.67% |
5 Year Returns | -6.64% |
Indian stocks brokerage services are provided by INDmoney Private Limited. INDmoney Private Limited is carrying out the business of in respect to stock broking activities and also carries out the activities of depository participant. SEBI Registration No. INZ000305337 | SEBI Depository Participant Registration No. IN-DP-690-2022 Depository Participant ID: CDSL 12095500 | Trading and Clearing Member of NSE (90267, M70042) and BSE (6779)
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are exemplary and not recommendatory. Past performance is not indicative of future returns.